AUROPHARMA.NS
Price:
$1225.1
Market Cap:
$711.54B
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In additio...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-01-15
Stock Exchange
NSE
Ticker
AUROPHARMA.NS
According to Aurobindo Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 20.79. This represents a change of 4.39% compared to the average of 19.92 of the last 4 quarters.
The mean historical PE Ratio of Aurobindo Pharma Limited over the last ten years is 16.09. The current 20.79 PE Ratio has changed 12.82% with respect to the historical average. Over the past ten years (40 quarters), AUROPHARMA.NS's PE Ratio was at its highest in in the September 2024 quarter at 26.08. The PE Ratio was at its lowest in in the December 2020 quarter at 4.58.
Average
16.09
Median
16.46
Minimum
8.51
Maximum
21.49
Discovering the peaks and valleys of Aurobindo Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 52.84%
Maximum Annual PE Ratio = 21.49
Minimum Annual Increase = -56.66%
Minimum Annual PE Ratio = 8.51
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 18.96 | -7.76% |
| 2024 | 20.56 | 30.54% |
| 2023 | 15.75 | 6.46% |
| 2022 | 14.79 | 52.84% |
| 2021 | 9.68 | 13.76% |
| 2020 | 8.51 | -56.66% |
| 2019 | 19.63 | 37.03% |
| 2018 | 14.33 | -16.55% |
| 2017 | 17.17 | -20.12% |
| 2016 | 21.49 | -5.03% |
The current PE Ratio of Aurobindo Pharma Limited (AUROPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.42
5-year avg
15.95
10-year avg
16.09
Aurobindo Pharma Limited’s PE Ratio is less than Alkem Laboratories Limited (28.13), less than Alkem Laboratories Limited (28.13), less than Lupin Limited (22.45), less than Laurus Labs Limited (82.49), less than Abbott India Limited (39.48), less than Lupin Limited (22.45), less than Laurus Labs Limited (82.49), less than Abbott India Limited (39.48), less than Glenmark Pharmaceuticals Limited (74.63), less than Glenmark Pharmaceuticals Limited (74.63),
| Company | PE Ratio | Market cap |
|---|---|---|
| 28.13 | $664.24B | |
| 28.13 | $664.96B | |
| 22.45 | $971.06B | |
| 82.49 | $564.26B | |
| 39.48 | $595.82B | |
| 22.45 | $971.02B | |
| 82.49 | $564.28B | |
| 39.48 | $595.72B | |
| 74.63 | $562.17B | |
| 74.63 | $561.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurobindo Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aurobindo Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aurobindo Pharma Limited's PE Ratio?
How is the PE Ratio calculated for Aurobindo Pharma Limited (AUROPHARMA.NS)?
What is the highest PE Ratio for Aurobindo Pharma Limited (AUROPHARMA.NS)?
What is the 3-year average PE Ratio for Aurobindo Pharma Limited (AUROPHARMA.NS)?
What is the 5-year average PE Ratio for Aurobindo Pharma Limited (AUROPHARMA.NS)?
How does the current PE Ratio for Aurobindo Pharma Limited (AUROPHARMA.NS) compare to its historical average?